Crystalloid (Ringer s Solution) Versus Colloid

Aim: Various crystalloid and colloidal solutions are used to prime the cardiopulmonary bypass (CPB) system. The aim of our study was to compare the effects of crystalloids and colloids used as priming solution during CPB. Methods: After the hospital scientific committee approval, informed consent wa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Haseki tıp bülteni 2015-06, Vol.53 (2), p.157-161
Hauptverfasser: Söğüt, Funda, Kudsioğlu, Türkan, Yapıcı, Nihan, Maçika, Hüseyin, Aykaç, Zuhal
Format: Artikel
Sprache:eng ; tur
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 161
container_issue 2
container_start_page 157
container_title Haseki tıp bülteni
container_volume 53
creator Söğüt, Funda
Kudsioğlu, Türkan
Yapıcı, Nihan
Maçika, Hüseyin
Aykaç, Zuhal
description Aim: Various crystalloid and colloidal solutions are used to prime the cardiopulmonary bypass (CPB) system. The aim of our study was to compare the effects of crystalloids and colloids used as priming solution during CPB. Methods: After the hospital scientific committee approval, informed consent was obtained from 40 patients undergoing elective coronary artery bypass grafting (CABG). The patients were prospectively randomized to group 1 (n=20) receiving crystalloid as priming volume and to group 2 (n=20) receiving colloid (20 ml/kg) 6% HES 130/0.4. Anaesthesia and CPB were standardized. Haemodynamic measurements were recorded. Laboratory parameters and plasma colloid osmotic pressures were measured. Results: Cardiac index was higher in colloid group than in crystalloid group after CPB. Plasma colloid osmotic pressure levels were lower in crystalloid group than in colloid group. Postoperative bleeding and renal function were similar in both groups. Conclusion: Crystalloids can be used as prime solution for effective haemodilution but they lack oncotic activity. In this study, we concluded that HES 130/0.4 has clinical efficiency and safety as a priming solution for CPB in adult patients. (The Me­di­cal Bul­le­tin of Ha­se­ki 2015; 53:157-61)
doi_str_mv 10.4274/haseki.2237
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1789513364</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4059289561</sourcerecordid><originalsourceid>FETCH-LOGICAL-c644-2f4ff5352aae332ef6c1f21f62018be8f3c9741b419f59f7c71367c5eb1b793c3</originalsourceid><addsrcrecordid>eNotkE1LxDAURYMoWMZZ-QcKbhRpzXtJm2QpxS8YEHRwG9KYaMfajMl0Mf_ejvVu7uZwLxxCzoGWHAW_-TTJfXUlIhNHJEPgosBaymOSAaNYUCrwlCxT2tApXAFImZGyifu0M30fuvf88qUbPlzMU_4a-nHXheEqf3MxjSlvwh9yRk686ZNb_veCrO_v1s1jsXp-eGpuV4WtOS_Qc-8rVqExjjF0vrbgEXyNFGTrpGdWCQ4tB-Ur5YUVwGphK9dCKxSzbEEu5tltDD-jSzu9CWMcpkcNQqoKGKv5RF3PlI0hpei83sbu28S9BqoPSvSsRB-UsF-VMFMO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1789513364</pqid></control><display><type>article</type><title>Crystalloid (Ringer s Solution) Versus Colloid</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Söğüt, Funda ; Kudsioğlu, Türkan ; Yapıcı, Nihan ; Maçika, Hüseyin ; Aykaç, Zuhal</creator><creatorcontrib>Söğüt, Funda ; Kudsioğlu, Türkan ; Yapıcı, Nihan ; Maçika, Hüseyin ; Aykaç, Zuhal</creatorcontrib><description>Aim: Various crystalloid and colloidal solutions are used to prime the cardiopulmonary bypass (CPB) system. The aim of our study was to compare the effects of crystalloids and colloids used as priming solution during CPB. Methods: After the hospital scientific committee approval, informed consent was obtained from 40 patients undergoing elective coronary artery bypass grafting (CABG). The patients were prospectively randomized to group 1 (n=20) receiving crystalloid as priming volume and to group 2 (n=20) receiving colloid (20 ml/kg) 6% HES 130/0.4. Anaesthesia and CPB were standardized. Haemodynamic measurements were recorded. Laboratory parameters and plasma colloid osmotic pressures were measured. Results: Cardiac index was higher in colloid group than in crystalloid group after CPB. Plasma colloid osmotic pressure levels were lower in crystalloid group than in colloid group. Postoperative bleeding and renal function were similar in both groups. Conclusion: Crystalloids can be used as prime solution for effective haemodilution but they lack oncotic activity. In this study, we concluded that HES 130/0.4 has clinical efficiency and safety as a priming solution for CPB in adult patients. (The Me­di­cal Bul­le­tin of Ha­se­ki 2015; 53:157-61)</description><identifier>ISSN: 1302-0072</identifier><identifier>EISSN: 2147-2688</identifier><identifier>DOI: 10.4274/haseki.2237</identifier><language>eng ; tur</language><publisher>Istanbul: Galenos Publishing House</publisher><ispartof>Haseki tıp bülteni, 2015-06, Vol.53 (2), p.157-161</ispartof><rights>Copyright Galenos Yayinevi Jun 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Söğüt, Funda</creatorcontrib><creatorcontrib>Kudsioğlu, Türkan</creatorcontrib><creatorcontrib>Yapıcı, Nihan</creatorcontrib><creatorcontrib>Maçika, Hüseyin</creatorcontrib><creatorcontrib>Aykaç, Zuhal</creatorcontrib><title>Crystalloid (Ringer s Solution) Versus Colloid</title><title>Haseki tıp bülteni</title><description>Aim: Various crystalloid and colloidal solutions are used to prime the cardiopulmonary bypass (CPB) system. The aim of our study was to compare the effects of crystalloids and colloids used as priming solution during CPB. Methods: After the hospital scientific committee approval, informed consent was obtained from 40 patients undergoing elective coronary artery bypass grafting (CABG). The patients were prospectively randomized to group 1 (n=20) receiving crystalloid as priming volume and to group 2 (n=20) receiving colloid (20 ml/kg) 6% HES 130/0.4. Anaesthesia and CPB were standardized. Haemodynamic measurements were recorded. Laboratory parameters and plasma colloid osmotic pressures were measured. Results: Cardiac index was higher in colloid group than in crystalloid group after CPB. Plasma colloid osmotic pressure levels were lower in crystalloid group than in colloid group. Postoperative bleeding and renal function were similar in both groups. Conclusion: Crystalloids can be used as prime solution for effective haemodilution but they lack oncotic activity. In this study, we concluded that HES 130/0.4 has clinical efficiency and safety as a priming solution for CPB in adult patients. (The Me­di­cal Bul­le­tin of Ha­se­ki 2015; 53:157-61)</description><issn>1302-0072</issn><issn>2147-2688</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNotkE1LxDAURYMoWMZZ-QcKbhRpzXtJm2QpxS8YEHRwG9KYaMfajMl0Mf_ejvVu7uZwLxxCzoGWHAW_-TTJfXUlIhNHJEPgosBaymOSAaNYUCrwlCxT2tApXAFImZGyifu0M30fuvf88qUbPlzMU_4a-nHXheEqf3MxjSlvwh9yRk686ZNb_veCrO_v1s1jsXp-eGpuV4WtOS_Qc-8rVqExjjF0vrbgEXyNFGTrpGdWCQ4tB-Ur5YUVwGphK9dCKxSzbEEu5tltDD-jSzu9CWMcpkcNQqoKGKv5RF3PlI0hpei83sbu28S9BqoPSvSsRB-UsF-VMFMO</recordid><startdate>20150605</startdate><enddate>20150605</enddate><creator>Söğüt, Funda</creator><creator>Kudsioğlu, Türkan</creator><creator>Yapıcı, Nihan</creator><creator>Maçika, Hüseyin</creator><creator>Aykaç, Zuhal</creator><general>Galenos Publishing House</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20150605</creationdate><title>Crystalloid (Ringer s Solution) Versus Colloid</title><author>Söğüt, Funda ; Kudsioğlu, Türkan ; Yapıcı, Nihan ; Maçika, Hüseyin ; Aykaç, Zuhal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c644-2f4ff5352aae332ef6c1f21f62018be8f3c9741b419f59f7c71367c5eb1b793c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; tur</language><creationdate>2015</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Söğüt, Funda</creatorcontrib><creatorcontrib>Kudsioğlu, Türkan</creatorcontrib><creatorcontrib>Yapıcı, Nihan</creatorcontrib><creatorcontrib>Maçika, Hüseyin</creatorcontrib><creatorcontrib>Aykaç, Zuhal</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Haseki tıp bülteni</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Söğüt, Funda</au><au>Kudsioğlu, Türkan</au><au>Yapıcı, Nihan</au><au>Maçika, Hüseyin</au><au>Aykaç, Zuhal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Crystalloid (Ringer s Solution) Versus Colloid</atitle><jtitle>Haseki tıp bülteni</jtitle><date>2015-06-05</date><risdate>2015</risdate><volume>53</volume><issue>2</issue><spage>157</spage><epage>161</epage><pages>157-161</pages><issn>1302-0072</issn><eissn>2147-2688</eissn><abstract>Aim: Various crystalloid and colloidal solutions are used to prime the cardiopulmonary bypass (CPB) system. The aim of our study was to compare the effects of crystalloids and colloids used as priming solution during CPB. Methods: After the hospital scientific committee approval, informed consent was obtained from 40 patients undergoing elective coronary artery bypass grafting (CABG). The patients were prospectively randomized to group 1 (n=20) receiving crystalloid as priming volume and to group 2 (n=20) receiving colloid (20 ml/kg) 6% HES 130/0.4. Anaesthesia and CPB were standardized. Haemodynamic measurements were recorded. Laboratory parameters and plasma colloid osmotic pressures were measured. Results: Cardiac index was higher in colloid group than in crystalloid group after CPB. Plasma colloid osmotic pressure levels were lower in crystalloid group than in colloid group. Postoperative bleeding and renal function were similar in both groups. Conclusion: Crystalloids can be used as prime solution for effective haemodilution but they lack oncotic activity. In this study, we concluded that HES 130/0.4 has clinical efficiency and safety as a priming solution for CPB in adult patients. (The Me­di­cal Bul­le­tin of Ha­se­ki 2015; 53:157-61)</abstract><cop>Istanbul</cop><pub>Galenos Publishing House</pub><doi>10.4274/haseki.2237</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1302-0072
ispartof Haseki tıp bülteni, 2015-06, Vol.53 (2), p.157-161
issn 1302-0072
2147-2688
language eng ; tur
recordid cdi_proquest_journals_1789513364
source DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals
title Crystalloid (Ringer s Solution) Versus Colloid
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T18%3A36%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Crystalloid%20(Ringer%20s%20Solution)%20Versus%20Colloid&rft.jtitle=Haseki%20t%C4%B1p%20b%C3%BClteni&rft.au=S%C3%B6%C4%9F%C3%BCt,%20Funda&rft.date=2015-06-05&rft.volume=53&rft.issue=2&rft.spage=157&rft.epage=161&rft.pages=157-161&rft.issn=1302-0072&rft.eissn=2147-2688&rft_id=info:doi/10.4274/haseki.2237&rft_dat=%3Cproquest_cross%3E4059289561%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1789513364&rft_id=info:pmid/&rfr_iscdi=true